JAG1 |
JAG1, JAGL1: Jagged-1 precursor |
NOTCH2 |
NOTCH2: Neurogenic locus notch homolog protein 2 precursor |
90.900 |
Evidence |
O
|
F9 |
F9: Coagulation factor IX precursor |
SERPINB4 |
SERPINB4, SCCA2: Serpin B4 |
90.900 |
Evidence |
|
GNAT2 |
GNAT2, GNATC: Guanine nucleotide-binding protein G(t), alpha-2 subunit |
SSTR2 |
SSTR2: Somatostatin receptor type 2 |
90.900 |
Evidence |
|
HCN3 |
HCN3, KIAA1535: Potassium/sodium hyperpolarization-activated cyclic nucleotide-g |
HCN2 |
HCN2, BCNG2: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gate |
90.900 |
Evidence |
|
F10 |
F10: Coagulation factor X precursor |
SERPINB4 |
SERPINB4, SCCA2: Serpin B4 |
90.900 |
Evidence |
|
HTR2A |
HTR2A, HTR2: 5-hydroxytryptamine receptor 2A |
GNA11 |
GNA11, GA11: Guanine nucleotide-binding protein subunit alpha-11 |
90.900 |
Evidence |
O
|
GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
CHRM5 |
CHRM5: Muscarinic acetylcholine receptor M5 |
90.900 |
Evidence |
|
CHRM5 |
CHRM5: Muscarinic acetylcholine receptor M5 |
GNA11 |
GNA11, GA11: Guanine nucleotide-binding protein subunit alpha-11 |
90.900 |
Evidence |
|
GNA11 |
GNA11, GA11: Guanine nucleotide-binding protein subunit alpha-11 |
SSTR2 |
SSTR2: Somatostatin receptor type 2 |
90.900 |
Evidence |
|
GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
HTR2A |
HTR2A, HTR2: 5-hydroxytryptamine receptor 2A |
90.900 |
Evidence |
|
GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
LHCGR |
LHCGR, LCGR, LGR2, LHRHR: Lutropin-choriogonadotropic hormone receptor precursor |
90.900 |
Evidence |
|
SSTR2 |
SSTR2: Somatostatin receptor type 2 |
GNAI1 |
GNAI1: Guanine nucleotide-binding protein G(i), alpha-1 subunit |
90.900 |
Evidence |
|
F2 |
F2: Prothrombin precursor |
SERPINB4 |
SERPINB4, SCCA2: Serpin B4 |
90.900 |
Evidence |
|
GNAZ |
GNAZ: Guanine nucleotide-binding protein G(z) subunit alpha |
SSTR1 |
SSTR1: Somatostatin receptor type 1 |
90.900 |
Evidence |
|
KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
90.880 |
Evidence |
|
NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
90.880 |
Evidence |
|
KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
CRKL |
CRKL: Crk-like protein |
90.880 |
Evidence |
|
FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
90.880 |
Evidence |
|
FGFR4 |
FGFR4, JTK2, TKF: Fibroblast growth factor receptor 4 precursor |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
90.880 |
Evidence |
|
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
90.880 |
Evidence |
|
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
90.720 |
Evidence |
|
PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
90.720 |
Evidence |
|
PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
90.720 |
Evidence |
|
ACTA1 |
ACTA1, ACTA: Actin, alpha skeletal muscle |
CFL1 |
CFL1, CFL: Cofilin-1 |
90.080 |
Evidence |
O
|
CHMP2A |
CHMP2A, BC2, CHMP2: Charged multivesicular body protein 2a |
VPS24 |
VPS24, CHMP3, CGI-149, NEDF: Charged multivesicular body protein 3 |
89.960 |
Evidence |
|